title: Successful therapy of chronic renal allograft failure by enhanced immunosuppression.
authors.affiliation: Abteilung Nephrologie, Medizinische Hochschule Hannover, Hannover, Germany.
authors.forename: V
authors.initials: V
authors.lastname: Kliem
authors.forename: T
authors.initials: T
authors.lastname: Tiroke
authors.forename: G
authors.initials: G
authors.lastname: Ehlerding
authors.forename: O
authors.initials: O
authors.lastname: Eberhard
authors.forename: M
authors.initials: M
authors.lastname: Behrend
authors.forename: U
authors.initials: U
authors.lastname: Frei
authors.forename: K M
authors.initials: KM
authors.lastname: Koch
authors.forename: R
authors.initials: R
authors.lastname: Pichlmayr
authors.forename: R
authors.initials: R
authors.lastname: Brunkhorst
mesh_terms: D000961:Antilymphocyte Serum / Q000627:therapeutic use; D003404:Creatinine / Q000097:blood; D016572:Cyclosporine / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000188:drug therapy; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods*; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology* / Q000502:physiology; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D016853:Muromonab-CD3 / Q000627:therapeutic use; D011183:Postoperative Complications / Q000453:epidemiology; D011239:Prednisolone / Q000627:therapeutic use; D012189:Retrospective Studies; D014184:Transplantation, Homologous; D017211:Treatment Failure
chemical_list: D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents; D016853:Muromonab-CD3; D016572:Cyclosporine; D011239:Prednisolone; D003404:Creatinine; D008775:Methylprednisolone